You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-malignant hematologic diseases

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Blood and Marrow Transplant
  • Minneapolis, Minnesota
    Masonic Caner Center at University of Minnesota
May 23, 2022

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Acute Myeloid Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma Trial in Hangzhou (CD70 CAR T-cells)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • CD70 CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 26, 2021

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

    Recruiting
    • Hemoglobinopathy (Disorder)
    • +2 more
    • Haploidentical Hematopoietic Cell Transplantation
    • Saint Petersburg, Florida
      Johns Hopkins All Children's Hospital
    Sep 13, 2022

    Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Feb 2, 2022

    Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

    Not yet recruiting
    • Cancer Risk
    • +30 more
    • Samples
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 14, 2022

    Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

    Completed
    • Mucopolysaccharidosis I
    • +15 more
    • Human Placental Derived Stem Cell
    • Denver, Colorado
    • +2 more
    Oct 24, 2022

    Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

    Recruiting
    • Hematologic Diseases
    • Neoplasms
    • CD7 CAR-T cells injection
    • Allogeneic hematopoietic stem cell transplantation
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 11, 2023

    Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Malignant Hematological Diseases
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Jul 3, 2023

    Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

    Terminated
    Has Results
    • Non-Malignant Hematologic Disorders
    • New York, New York
      Memorial SloanKettering Cancer Center
    Mar 1, 2021

    Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

    Available
    • Hematologic Malignancies
    • +2 more
    • CliniMACS CD34 Reagent System
    • Durham, North Carolina
      Duke University Medical Center
    Nov 12, 2021

    Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies Trial in Canada, United States (Treatment

    Recruiting
    • Metabolic Disorders
    • +3 more
    • Treatment Plan 1: Stratum 1
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Oct 12, 2021

    Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)

    Not yet recruiting
    • Pediatric Patients
    • +2 more
    • CliniMACS Plus Instrument
    • Aurora, Colorado
      Children's Hospital Colorado
    Jun 29, 2022

    Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

    Recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • San Francisco, California
      • +15 more
      Jun 17, 2022

      Coronavirus Infection and Hematologic Diseases Trial in Russian Federation (Non-interventional study)

      Completed
      • Coronavirus Infection and Hematologic Diseases
      • Non-interventional study
      • Ekaterinburg, Russian Federation
      • +14 more
      Jan 25, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      Tissue Specimens From Solid Tumors or Blood Disorders and Their

      Recruiting
      • Neoplasms
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

        Not yet recruiting
        • Leukemia
        • +12 more
        • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
        • (no location specified)
        Mar 20, 2023

        Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

        Recruiting
        • Non Malignant Diseases
        • +2 more
        • RIC: Distal Campath
        • +2 more
        • Philadelphia, Pennsylvania
          The Children's Hospital of Philadelphia
        Mar 8, 2022

        Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

        Completed
        Has Results
        • Myeloproliferative Disorders
        • +4 more
        • T-cell replete PBPC allograft
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Oct 12, 2022

        Study of Non-Neoplastic Hematologic Disorders

        Recruiting
        • Hematologic Disorder
        • +8 more
          • Phoenix, Arizona
          • +9 more
          May 18, 2022

          Hematologic Diseases, Chemo Effect Trial in France (MaaT033 capsule)

          Completed
          • Hematologic Diseases
          • Chemotherapy Effect
          • MaaT033 capsule
          • Angers, France
          • +3 more
          Apr 11, 2022

          Maxillary Sinus Disease, Approach-Approach Conflict Trial in Tanta (endoscopic maxillary mega-antrostomy, Endoscopic Modified

          Recruiting
          • Maxillary Sinus Disease
          • Approach-Approach Conflict
          • endoscopic maxillary mega-antrostomy
          • +2 more
          • Tanta, Gharbia Government, Egypt
            Faculty of medicine
          Aug 7, 2022

          Sickle Cell Disease, Multiple Myeloma Trial in Washington

          Enrolling by invitation
          • Sickle Cell Disease
          • Multiple Myeloma
            • Washington, District of Columbia
              ASH Research Collaborative
            Mar 7, 2023